SRGN and breast cancer: We wanted to understand the association between SRGN gene expression and breast cancer progression and metastasis, and collected a panel of breast cancer tissue samples and divided them into a positive lymph node metastases group (Node positive) (n=135) and a negative lymph node metastases group (Node negative) (n=142).